Berenberg Bank analyst Gaurav Goparaju maintained a Buy rating on 23andMe Holding (ME – Research Report) today and set a price target of $6.00. The company’s shares opened today at $1.89.
Goparaju covers the Healthcare sector, focusing on stocks such as Ginkgo Bioworks Holdings, Relay Therapeutics, and AbCellera Biologics. According to TipRanks, Goparaju has an average return of -3.6% and a 40.00% success rate on recommended stocks.
Currently, the analyst consensus on 23andMe Holding is a Strong Buy with an average price target of $4.88.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $6.31 and a one-year low of $1.57. Currently, 23andMe Holding has an average volume of 2.39M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
VG Acquisition Corp is a blank check company.
Read More on ME:
- 23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin
- 23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks
- 23andMe Stock (NASDAQ:ME): Layoffs on the Horizon
- 23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
- ME Earnings this Week: How Will it Perform?
